methylmalonic acid has been researched along with Recrudescence in 4 studies
Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B(12) deficiency, might predispose to new cardiovascular events following an acute myocardial infarction (MI)." | 7.74 | Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. ( Aarsetøy, H; Grundt, H; Mansoor, MA; Nilsen, DW; Reine, A; Valente, E, 2008) |
| "To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B(12) deficiency, might predispose to new cardiovascular events following an acute myocardial infarction (MI)." | 3.74 | Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. ( Aarsetøy, H; Grundt, H; Mansoor, MA; Nilsen, DW; Reine, A; Valente, E, 2008) |
| "Malignant hypertension was diagnosed." | 1.40 | Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency. ( Benoist, JF; Cornec-Le Gall, E; De Parscau, L; Delmas, Y; Doucet, L; Fremeaux-Bacchi, V; Le Meur, Y; Ogier, H, 2014) |
| " Weight and methylmalonic acid (MMA) level were predictive of pharmacokinetic (PK) variability." | 1.35 | A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma. ( Duffull, SB; Fleisher, M; Hamlin, P; Horwitz, S; Mould, DR; Neylon, E; O'Connor, OA; Saunders, ME; Sirotnak, F; Sweeney, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornec-Le Gall, E | 1 |
| Delmas, Y | 1 |
| De Parscau, L | 1 |
| Doucet, L | 1 |
| Ogier, H | 1 |
| Benoist, JF | 1 |
| Fremeaux-Bacchi, V | 1 |
| Le Meur, Y | 1 |
| Kamoun, F | 1 |
| Guirat, R | 1 |
| Megdich, F | 1 |
| Ben Ameur, S | 1 |
| Kallel, C | 1 |
| Hachicha, M | 1 |
| Mould, DR | 1 |
| Sweeney, K | 1 |
| Duffull, SB | 1 |
| Neylon, E | 1 |
| Hamlin, P | 1 |
| Horwitz, S | 1 |
| Sirotnak, F | 1 |
| Fleisher, M | 1 |
| Saunders, ME | 1 |
| O'Connor, OA | 1 |
| Aarsetøy, H | 1 |
| Valente, E | 1 |
| Reine, A | 1 |
| Mansoor, MA | 1 |
| Grundt, H | 1 |
| Nilsen, DW | 1 |
4 other studies available for methylmalonic acid and Recrudescence
| Article | Year |
|---|---|
Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Antibodies, Monoclonal, Humanized; Betaine; Biopsy; Car | 2014 |
Frequent Infections, Hypotonia, and Anemia in a Breastfed Infant.
Topics: Adult; Agammaglobulinemia; Anemia, Megaloblastic; Anemia, Pernicious; Asymptomatic Diseases; Breast | 2017 |
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Area Under Curve; Biomarkers; Body Size; Drug Admin | 2009 |
Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Homocysteine; Humans; | 2008 |